EQIX insider files resale of 2,935 restricted shares
Company EQIX reported proposed sales of 2,935 shares of Common Stock represented by Restricted Stock Units, with the filing listing Nasdaq as the market and an accompanying prior 10b5-1 sale of 1,086 shares on 03/12/2026 valued at $1,049,295.26.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Company EQIX reported proposed sales of 2,935 shares of Common Stock represented by Restricted Stock Units, with the filing listing Nasdaq as the market and an accompanying prior 10b5-1 sale of 1,086 shares on 03/12/2026 valued at $1,049,295.26. The filing lists Morgan Stanley Smith Barney LLC as the broker.
Insights
Routine Form 144 sale notice under a 10b5-1 plan; procedural disclosure.
The filing documents proposed resale of 2,935 shares via Restricted Stock Units and records a prior 10b5-1 sale of 1,086 shares on 03/12/2026 for $1,049,295.26. The broker listed is Morgan Stanley Smith Barney LLC.
Compliance focus: ensure sale timing and broker reporting conform to Rule 144 and any 10b5-1 plan terms. Subsequent filings will show actual settlement and any additional dispositions.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Units financial
10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does EQIX Form 144 disclose about insider sales?
Who acted as broker for the EQIX transactions in the filing?
Are the securities in the EQIX filing restricted or unrestricted?
AI-generated analysis. How Rhea-AI works. Not financial advice.